key: cord-0766328-vkzx750j
authors: D'Cruz, Rebecca F.; Waller, Michael D.; Perrin, Felicity; Periselneris, Jimstan; Norton, Sam; Smith, Laura-Jane; Patrick, Tanya; Walder, David; Heitmann, Amadea; Lee, Kai; Madula, Rajiv; McNulty, William; Macedo, Patricia; Lyall, Rebecca; Warwick, Geoffrey; Galloway, James B.; Birring, Surinder S.; Patel, Amit; Patel, Irem; Jolley, Caroline J.
title: Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia
date: 2020-10-22
journal: ERJ Open Res
DOI: 10.1183/23120541.00655-2020
sha: 7109ae7c20641fd4bbc1c0723758854ae6166d77
doc_id: 766328
cord_uid: vkzx750j

BACKGROUND: A standardised approach to assessing COVID-19 survivors has not been established, largely due to the paucity of data on medium- and long-term sequelae. Interval chest radiograph is recommended following community-acquired pneumonia, however its utility in monitoring recovery from COVID-19 pneumonia remains unclear. METHODS: Prospective single-centre observational cohort study. Patients hospitalised with severe COVID-19 pneumonia (admission duration ≥48 h and oxygen requirement ≥40% or critical care admission) underwent face-to-face assessment 4–6 weeks post-discharge. Primary outcome: radiological resolution of COVID-19 pneumonitis (Radiographic Assessment of Lung Oedema score <5). Secondary outcomes: clinical outcomes, symptom questionnaires, mental health screening (Trauma Screening Questionnaire, GAD-7, PHQ-9), physiological testing (4-metre gait speed (4MGS), 1-minute sit-to-stand test (STS)). RESULTS: 119 patients assessed between 3(rd) June and 2(nd) July 2020 at median (IQR) 61 (51–67) days post-discharge. Mean±sd age 58.7±14.4 years, body mass index 30.0 (25.9–35.2) kg·m(−2), 62% male, 68% ethnic minority. Despite radiographic resolution of pulmonary infiltrates in 87%, mMRC breathlessness scores were above pre-COVID baseline in 46% and patients reported persistent fatigue (68%), sleep disturbance (57%) and breathlessness (32%). Screening thresholds were breached for post-traumatic stress disorder (25%), anxiety (22%) and depression (18%). 4MGS was slow (<0.8 m·s(−1)) in 38%, 35% desaturated by ≥4% during STS. Of 56 thoracic computed tomography scans performed, 75% demonstrated COVID-related interstitial and/or airways disease. CONCLUSIONS: Persistent symptoms, adverse mental health outcomes and physiological impairment are common 2 months after severe COVID-19 pneumonia. Follow-up chest radiograph is a poor marker of recovery, therefore holistic face-to-face assessment is recommended to facilitate early recognition and management of post-COVID sequelae.

Following alarmingly rapid global spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 was categorised as a pandemic on 11 th March 2020 [1] . Acute manifestations of the disease are widely reported, with fever, cough and breathlessness recognised as the most common presenting symptoms [2] . Following the acute phase of illness, there is increasing anecdotal awareness of patients with "long COVID" in whom residual symptoms persist beyond the acute viral illness [3] . However, a robust evidence base on medium-and long-term physical and psychological sequelae of severe COVID-19 infection is currently lacking.

Drawing from experience from previous coronavirus global outbreaks ( critical illness, COVID-19 survivors are anticipated to be at risk of impaired lung function [4] , interstitial lung disease [5] , exercise limitation and impaired quality of life in the months and years following hospital discharge [4, 6, 7] . Given the 14% prevalence of post-traumatic stress disorder in critical illness survivors [8] and excess increase in mental distress observed amongst UK adults during the COVID-19 pandemic [9] , the burden of mental health disorders following COVID-19 infection is expected to be high. With over 24 million cases now confirmed globally and the daily incidence continuing to climb [10] , it is apparent that early recognition and management of complications amongst the increasing population of severe COVID-19 survivors, many of whom will have experienced multi-organ involvement, critical care admission and psychological trauma, is a clinical priority.

We aimed to prospectively investigate clinical, radiological, functional and psychological COVID-19

sequalae of severe COVID-19 pneumonia, and to identify factors associated with symptomatic and functional recovery.

This single-centre prospective observational cohort study was conducted at King's College Hospital, an urban university hospital in London (UK). We analysed the routine data of COVID-19 survivors attending the King's College Hospital COVID-19 post-discharge clinical service. To identify patients hospitalised with COVID-19 pneumonia, we screened electronic medical records of consecutive patients aged 18 years and above hospitalised with PCR-confirmed COVID-19 on naso-and oropharyngeal swab between February and May 2020. In the UK healthcare system during the pandemic, patients presenting to the emergency department with symptoms consistent with COVID- 19 were admitted to hospital if they were considered at higher risk of severe disease (based on age, comorbidities or social circumstances) and/or they had significantly abnormal vital observations or investigations (venous or arterial blood results, chest radiography). We defined severe COVID-19

pneumonia as requiring hospitalisation for ≥48 hours and a fraction of inspired oxygen (FiO 2 ) of ≥40% or intensive care unit (ICU) admission. Patients fulfilling these criteria and surviving to discharge were invited to attend clinic for face-to-face assessment in accordance with British Thoracic Society (BTS)

Guidance [11] . Herein, we report the first month of prospectively collected data from consecutive patients assessed between 3 rd June and 2 nd July 2020. This study was approved by the Clinical Governance committee, King's College NHS Foundation Trust, judged to be a service evaluation exempt from NHS Research Ethics Committee review, since no a priori hypothesis testing, randomisation or treatment allocation was undertaken, and conducted according to the principles of the Declaration of Helsinki [12] .

Demographic and anthropometric data and inpatient clinical outcomes for all patients screened were obtained from medical records. A summary of follow-up data collected is provided in Table S1 .

Questionnaires were used to evaluate persistent symptoms, self-reported functional disability, depression, anxiety, post-traumatic stress disorder (PTSD) and cognition [13] [14] [15] [16] [17] [18] [19] [20] . Functional disability was objectively assessed using the 4-metre gait speed (4MGS) and 1-minute sit-to-stand (STS) test [21, 22] . Admission, worst inpatient and follow-up radiographs were graded using the Radiographic Assessment of Lung Oedema (RALE) score [23] . Thoracic computed tomography (CT) scans were performed for patients with persistent chest radiograph abnormalities, respiratory symptoms or desaturation of ≥4% during STS. Additional methodological details are provided in the online supplement.

The primary outcome of this study was radiological resolution of COVID-19 pneumonia, in accordance with national guidelines [11] . Secondary outcomes included demographics, anthropometrics, inpatient clinical course, symptom questionnaires, mental health screening and physiological testing (STS repetitions and oxygen desaturation and 4MGS).

The aim of this study was to perform rapid characterisation of severe 

Between 3 rd June and 2 nd July 2020, 143 patients were invited to attend face-to-face assessment post-discharge, 119 attended. These patients had been hospitalised between 5 th March and 28 th May 2020, during which time a total of 898 patients were hospitalised with confirmed COVID-19, of whom 657 survived to discharge ( Figure 1 ). Data for all patients hospitalised with COVID-19, those surviving to discharge and those that did not attend their post-COVID clinic appointment and between-group comparisons are provided in Tables S2-3 . Baseline demographic and anthropometric characteristics at follow-up and patients' inpatient clinical course are presented in Table 1 (Table   S4 ), of which acute kidney injury (35%) and venous thromboembolism (23%) were most common. Data presented as mean ± standard deviation, median (interquartile range) or frequency (proportion; 95% confidence interval). attended the Emergency Department, 9 (16%) were re-hospitalised, 9 (16%) attended planned outpatient appointments for pre-existing co-morbidities.

Questionnaire scores are displayed in Figure 3 . mMRC scale at follow-up was 1 (0-2) and pre-COVID Odd ratios adjusted for age and sex. mMRC = modified Medical Research Council score for breathlessness, PCFS = post-covid functional scale, OR = odd ratio, 95%CI = 95% confidence interval, BAME = Black, Asian or minority ethnic, IMD = index of multiple deprivation score, BMI = body mass index, LOS = length of stay, FMO2 = facemask oxygen, PaO2:FiO2 = arterial partial pressure of oxygen to fraction of inspired oxygen ratio, ICU = intensive care unit, IMV = invasive mechanical ventilation, VTE = venous thromboembolism, RALE = radiographic assessment of lung oedema, CT = computed tomography, NRS = numerical rating score, 6CIT = 6-item cognitive impairment test, 4MGS = 4-metre gait speed, STS = sit-to-stand Categorial data are presented as frequency (proportion; 95% confidence interval, continuous data are presented as mean ± SD, median (IQR). 4MGS = 4-metre gait speed, STS = sit-to-stand, SpO2 = peripheral oxygen saturation, p<2.5 = patients below 2. desaturation during STS testing). Only 21% of patients with abnormal CT findings also had an abnormal follow-up chest radiograph, however 78% of those with ≥4% desaturation during STS also had abnormal CT findings. 33 patients had a normal chest radiograph (RALE score 0-4) and an abnormal CT, 9 patients had both an abnormal chest radiograph (RALE score >4) and abnormal CT.

Amongst those with abnormal CT scans, presence or absence of radiographic abnormalities was not predictive of any patient-reported or physiological outcome measure.

Ordinal logistic regression modelling was performed for the outcomes of return of mMRC to pre-COVID baseline, PCFS score of ≥2, positive mental health screening (PHQ-9 or GAD-7 ≥9 or Trauma Screening Questionnaire ≥6) and physiological functional impairment (4MGS <0.8 m/s, STS repetitions in <2.5 percentile or ≥4% desaturation on STS) ( Table 3 ). Positive associations were found between PCFS score of ≥2, physiological impairment (4MGS <0.8 m/s and STS repetitions in <2.5 percentile) and positive mental health screening. Critical care admission and need for invasive mechanical ventilation were associated with physiological functional impairment. Neither worst inpatient nor follow-up RALE score were associated with any modelled outcome measure.

This is the first study to provide holistic characterisation of medium-term sequelae two months following severe COVID-19 pneumonia incorporating clinical, radiological, physiological and psychological outcome measures. At 7-9 weeks following index hospitalisation, chest radiograph was a poor marker of abnormal CT findings and persistent functional disability. 87% of patients had a RALE score of 0-4. 75% of CT scans demonstrated COVID-related interstitial lung disease and/or airways disease however only 21% of patients with abnormal CT findings also had an abnormal follow-up chest radiograph.

The burdens of persistent symptoms, mental health disorders and functional disability 2 months following index hospitalisation were high, with persistent fatigue (68%) and sleep disturbance (57%) more prevalent than respiratory symptoms (breathlessness 32%, cough 7%). Significant depression or anxiety was present in 18% and 22% of patients, respectively, and 25% screened positive for post- [2, 26] . High rates of inpatient complications attributable to COVID-19 were observed, comparable to published data, including venous thromboembolism, acute kidney injury, deranged liver function and delirium [2, 27, 28] . Follow-up patients were younger with fewer co-morbidities than the total cohort surviving to discharge, likely representing the characteristics of COVID-19 survivors, since these have been identified as risk factors for inpatient mortality in retrospective analyses [29, 30] .

Few data are available on medium-and long-term effects of COVID-19 following hospital discharge.

Our population characteristics are consistent with an Italian post-COVID clinic cohort who had comparable quality of life impairment and persistent symptoms, although these patients were seen sooner following hospital discharge (36±13days compared to 61 (51-67) days) [31] . Compared to studies evaluating radiological sequelae of MERS-CoV, the proportion of patients with chest x-ray resolution was much larger in our cohort (87% measured 76 (71-83) days from admission, compared to 64% measured at 32-230 days) [32] . Data on post-COVID CT findings are currently limited to within 3 weeks of symptom onset and indicate rapid evolution from unilateral multifocal ground-glass opacities to bilateral diffuse involvement to early reductions in ground-glass opacities by week 2 [33] .

This is the first study to report CT outcomes post-discharge. We did not perform CT scans indiscriminately and would therefore anticipate that this selection would lead to overrepresentation of interstitial abnormalities. Conversely, interstitial changes were less common in our cohort compared to patients with previous SARS, in whom 15 (62%) of 24 patients exhibited fibrotic changes on CT [5] .

15-year longitudinal data from SARS patients demonstrates resolution or stability of ground-glass changes with corresponding stability of total lung capacity and carbon monoxide diffusing capacity on lung function testing [34] . The long-term clinical implications and prognosis of COVID-related interstitial changes identified in the post-acute phase of illness remains unknown, and labelling these abnormalities as lung fibrosis appears premature, particularly given the lack of association between presence of CT abnormalities and any measure of patient-reported or physiological functional impairment in this cohort.

Prevalence of persistent and burdensome physical symptoms, patient-reported and physiological functional impairment and psychological sequelae was high in our cohort, and critical care admission and need for invasive mechanical ventilation were both associated with patient-reported and objective functional impairment. This is consistent with medium-and long-term data from acute respiratory distress syndrome and SARS survivors, in whom impaired quality of life and functional disability (measured using the 36-Item Short Form Survey and 6-minute walk test) were present at 3, 6 and 12 months following index hospitalisation [4, 7] . The burdens of patient-reported and physiological outcomes were high despite radiographic resolution occurring in the majority. Reasons for this remain speculative and may relate to our early assessment of patients with severe disease 61 (51-67) days post-discharge. Long-term data on post-COVID symptoms and functional outcomes are awaited.

Clinically significant depression or anxiety were present in 18% and 22% of our cohort, respectively, and 25% screened positive for post-traumatic stress disorder, consistent with published data (31% depression, 42% anxiety and 28% PTSD 1 month post-discharge) [35] .

Persistent symptoms of fatigue and sleep disturbance following severe COVID-19 pneumonia have implications for productivity, physical activity and mental health, reflected in the high rates of positive screening tests for anxiety, depression and PTSD observed in this cohort. Whilst causative mechanisms for adverse mental health outcomes following COVID-19 infection have not been established, mental distress at the population level has increased in excess of anticipated trajectories during the COVID-19 pandemic [9] . ICU-acquired weakness is a major contributor to adverse longterm physical and psychological sequelae of critical illness [6] and likely applicable to COVID-19survivors, particularly since conventional methods of rehabilitation and exercise have been limited [36] . It has also been speculated that biological pathophysiological mechanisms, relating to cerebral vascular inflammation and thrombosis, survivor guilt and isolation in COVID-19 survivors may also contribute to adverse mental health outcomes in this cohort [28, 35] .

Chest radiography 12 weeks post-discharge is advocated by current guidelines to evaluate recovery, with face-to-face clinical assessment recommended only in those with abnormal radiographs or those who experienced severe illness [11] . However, the majority (87%) of radiographs performed at followup demonstrated recovery (RALE score <5) despite the high prevalence of adverse patient-reported and/or physiological outcomes. The clinical implications of post-COVID interstitial changes identified on CT remain unclear. Of note, parenchymal abnormalities in SARS survivors demonstrated recovery and stability in the 2 years following infection [34] . We strongly encourage integrated holistic assessment of COVID-19 survivors using both radiological and clinical reviews, which may be conducted face-to-face or virtually depending on healthcare resources and patient preference.

The battery of outcome measures implemented in this study is impractical for routine clinical use.

Focussed patient interview is an appropriate substitute for questionnaires, utilising the data presented and we recommend routine application of functional exercise testing. The 4MGS and 1-minute STS are reliable and validated methods of assessing exercise performance, are predictive of health-related quality of life and correlate with other tests of functional capacity, including the incremental shuttle walk and 6-minute walk tests [21, 37, 38] . These self-paced tests were quick to perform, required simple instructions to the patients and minimal space, equipment and training and were completed in the majority of cases with no adverse events. Importantly, they provided valuable clinical information regarding oxygen desaturation and exercise limitation which was not obtained from other sources, thus identifying a cohort of patients requiring CT evaluation and who may benefit from pulmonary rehabilitation or advised on graded and paced return to usual activities, although current facilities and evidence in this context remains unestablished [39, 40] .

We rapidly designed a pragmatic clinical service to prospectively collect comprehensive data on physical and psychological recovery from severe COVID-19 at a time when sequelae of the acute illness were unknown and healthcare resources were severely strained. We conducted systematic face-to-face assessments which enabled collection of a wealth of clinical, radiological, patientreported and physiological data in a short period, with all outcome measures contributing to clinical decision making.

This study has some limitations. Firstly, it was not possible to perform lung function testing in serial patients due to decontamination procedures required following this aerosol generating procedure, limiting conclusions that can be drawn regarding respiratory sequelae of the disease [41] . Secondly, conventional field walking tests to evaluate exercise capacity (6-minute walk test (6MWT), incremental shuttle walk test (ISWT)) were impractical in the clinic setting. However, the 4MGS and STS are reliable, validated and pragmatic methods of assessing exercise performance that correlate with the 6MWT and ISWT, breathlessness and health-related quality of life [21, 37, 38] . Thirdly, given the ambiguity in current guidance we devised our own definition of "severe" COVID-19 pneumonia in order to assess patients at highest risk of complications and to rationalise resources, given the large number of COVID-19 admissions. This approach may have missed some patients with persistent symptoms or functional disability, however those recovering from mild to moderate disease are now being invited to attend post-COVID clinic and we plan to report their outcomes in due course. Finally, these data were collected from a single, urban teaching centre which limits the generalisability of our results. However, this dataset is sufficiently large to provide reasonable estimates of post-COVID sequelae whilst results of multicentre studies are awaited.

We have demonstrated that the burden of persistent symptoms, functional limitation and adverse mental health outcomes 2 months after severe COVID-19 pneumonia is high. Physiological impairments frequently persist despite apparent resolution of infiltrates on follow-up chest radiography. Routinely offering face-to-face post-COVID follow-up assessment permitted inclusion of self-paced "bedside" physiological tests, which provided valuable clinical information on functional 

Methods [1] [2] [3] [4] . For each symptom, patients selected an integer between zero (not present) and 10 (unbearable) that best reflected the intensity of the symptom in the preceding 24 hours. Symptoms were categorised as being present (score of ≥1) and burdensome (score of ≥4). Current and pre-COVID functional impairment was quantified using the 5-point modified

Medical Research Council (mMRC) Dyspnoea Scale [5] . The 16-point Nijmegen Questionnaire was used to screen for hyperventilation syndrome and dysfunctional breathing (cut off score of 23) [6] .

Anxiety and depression screening was performed using the PHQ-9 and GAD-7 questionnaires, in which patients score 7 and 9 questions respectively between zero (not at all) to three ("nearly every day") using a cut-off score of >9 [7, 8] . The Trauma Screening Questionnaire was used to screen for post-traumatic stress disorder (PTSD), with patients asked to review 10 items and endorse those experienced at least twice in the preceding two weeks, using a cut off score of ≥6 [9] . The 6-Item

Cognitive Impairment Test (6CIT) was used to screen for cognitive impairment [10] . The recently designed Post-COVID Functional Scale (PCFS) is a five-point scale used to reflect functional limitations during COVID-19 recovery and intended for use at 4-8 weeks and 6 months post-discharge [11] .

Functional disability was objectively assessed using the 4-metre gait speed (4MGS) and 1-minute sitto-stand (STS) test. Patients wore surgical masks continuously whilst on hospital premises, including during 4MGS and STS testing, thereby minimising aerosolisation of respiratory droplets. For the 4MGS, patients were timed whilst walking along an unobstructed 4-metre path at their usual speed, with their usual walking aids or oxygen if applicable, recording the fastest of two efforts and stratifying speeds as normal (≥0.8m/s) or slow (<0.8m/s). The 4MGS is a reliable and validated method of assessing exercise performance and frailty, and correlates with other tests of functional capacity, such as the incremental shuttle walk test, breathlessness and health-related quality of life (HRQoL) [12, 13] . For the STS, following a demonstration by the healthcare professional, patients were instructed to perform self-paced repetitions of sitting and standing from a chair for 1-minute. The number of repetitions, oxygen saturation and heart rate were recorded at baseline, end-exercise and during recovery, with repetitions categorised according to their percentile for age and sex [14] . The STS is a simple and highly reproducible measurement that correlates closely with other tests of functional capacity, including the 6-minute walk test (6MWT), and is predictive of mortality and HRQoL [15, 16] . Lung function testing was limited to urgent cases due to decontamination procedures required following this aerosol generating procedure [17] .

Admission, worst inpatient and follow-up radiographs were graded using the Radiographic Assessment of Lung Oedema (RALE) score [18] . This involves review of consolidation and density of alveolar opacities in lung quadrants and produces a score between zero and 48. The RALE validation study was used to define radiological recovery as scores between 0 and 4 [18] . Patients with persistent radiological abnormalities, respiratory symptoms or desaturation of ≥4% during the STS underwent thoracic computed tomography (CT). 

Timeline of WHO's response to COVID-19

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Covid-19: What do we know about "long covid"?

Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors

Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience

Functional disability 5 years after acute respiratory distress syndrome

One-year outcomes in survivors of the acute respiratory distress syndrome

Post-traumatic stress disorder after critical illness requiring general intensive care

Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population

British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia

Prevalence and Predictive Value of Dyspnea Ratings in Hospitalized Patients: Pilot Studies

Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

The PHQ-9: validity of a brief depression severity measure

A brief measure for assessing generalized anxiety disorder: the GAD-7

Brief screening instrument for post-traumatic stress disorder

Validation of a short Orientation-Memory-Concentration Test of cognitive impairment

Reliability and validity of 4-metre gait speed in COPD

Population-based reference values for the 1-min sit-to-stand test

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

Intensive Care National Audit & Research Centre (ICNARC). ICNARC report on COVID-19 in critical care

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Persistent Symptoms in Patients After Acute COVID-19

Follow-up chest radiographic findings in patients with MERS-CoV after recovery

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study

Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors

Covid-19: the challenge of patient rehabilitation after intensive care

Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease

Simple functional performance tests and mortality in COPD

COVID-19 and pulmonary rehabilitation: preparing for phase three

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial

Recommendation from ERS Group 9.1 (Respiratory function technologists /Scientists)Lung function testing during COVID-19 pandemic and beyond

Prevalence and Predictive Value of Dyspnea Ratings in Hospitalized Patients: Pilot Studies

Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report

Reliability and validity of a vertical numerical rating scale supplemented with a faces rating scale in measuring fatigue after stroke

Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia

Control of the end-tidal PCO2 in the hyperventilation syndrome: effects of biofeedback and breathing instructions compared

The PHQ-9: validity of a brief depression severity measure

A brief measure for assessing generalized anxiety disorder: the GAD-7

Brief screening instrument for post-traumatic stress disorder

Validation of a short Orientation-Memory-Concentration Test of cognitive impairment

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

Reliability and validity of 4-metre gait speed in COPD

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study

Population-based reference values for the 1-min sit-to-stand test

Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease

Simple functional performance tests and mortality in COPD

eds) Book Recommendation from ERS Group 9.1 (Respiratory function technologists /Scientists)Lung function testing during COVID-19 pandemic and beyond

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

We wish to acknowledge the dedication and commitment of the King's College Hospital staff in rapidly developing

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.Abbreviations: IQR = interquartile range, SD = standard deviation, BAME = Black, Asian, minority ethnic,  2 = Chi-square, 95% CI = 95% confidence interval